Literature DB >> 8797952

Influence of different fasting periods on P-31-MR-spectroscopy of the liver in normals and patients with liver metastases.

G Brinkmann1, U H Melchert, C Muhle, J Brossmann, J Link, M Reuter, M Heller.   

Abstract

The purpose of this study was to determine the influence of different fasting periods on the in vivo P-31-MR spectroscopy of the healthy liver and patients with liver metastases. Image-guided localized P-31-MRS was performed in 24 patients with liver metastases and in 20 healthy volunteers. The spectra were obtained with a whole body scanner operating at 1.5 T using a surface coil. The P-31-MRS was performed after a fasting period of 3-5 h (group 1) and after overnight fasting (group 2). The PME/beta-NTP, PDE/beta-NTP and Pi/beta-NTP were calculated from P-31-MR spectra and were compared in relation to the nutrition status of the volunteers and patients. The PME/beta-NTP and PDE/beta-NTP were significantly increased in spectra of patients with metastases. There were no significant changes in the ratios of phosphorus metabolites in healthy liver tissue or in liver metastases after a fasting period of 3-5 h as compared with overnight fasting.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8797952     DOI: 10.1007/bf00619955

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  12 in total

1.  Four-dimensional chemical shift MR imaging of phosphorus metabolites of normal and diseased human liver.

Authors:  I J Cox; D J Bryant; A G Collins; P George; R R Harman; A S Hall; H J Hodgson; S Khenia; P McArthur; D H Spencer
Journal:  J Comput Assist Tomogr       Date:  1988 May-Jun       Impact factor: 1.826

2.  Malignant hepatic tumors: P-31 MR spectroscopy with one-dimensional chemical shift imaging.

Authors:  I R Francis; T L Chenevert; B Gubin; L Collomb; W Ensminger; S Walker-Andrews; G M Glazer
Journal:  Radiology       Date:  1991-08       Impact factor: 11.105

3.  [The effect of parameter choice on results of localized in vivo MR spectroscopy].

Authors:  U Melchert; G Brinkmann; K Förger; F Wunsch-Binder
Journal:  Biomed Tech (Berl)       Date:  1989       Impact factor: 1.411

4.  [Equipment organization for in vivo study of 31-phosphor metabolism using magnetic resonance spectroscopy].

Authors:  K Förger; G Brinkmann; U Melchert; F Wunsch-Binder
Journal:  Biomed Tech (Berl)       Date:  1989       Impact factor: 1.411

5.  [The effect of nutritional status on the 31P MR spectrum of the normal liver].

Authors:  A Schilling; B Gewiese; D Stiller; T Römer; K J Wolf
Journal:  Rofo       Date:  1990-10

6.  Image localized 31P magnetic resonance spectroscopy of the human liver.

Authors:  G M Glazer; S R Smith; T L Chenevert; P A Martin; A N Stevens; R H Edwards
Journal:  NMR Biomed       Date:  1989-04       Impact factor: 4.044

7.  In vivo P-31-MR-spectroscopy of focal hepatic lesions. Effectiveness of tumor detection in clinical practice and experimental studies of surface coil characteristics and localization technique.

Authors:  G Brinkmann; U H Melchert; L Emde; H Wolf; C Muhle; J Brossmann; M Reuter; M Heller
Journal:  Invest Radiol       Date:  1995-01       Impact factor: 6.016

8.  [31P-MR spectroscopy of liver diseases with reference to variable pulse recovery times].

Authors:  G Brinkmann; U H Melchert; G Lalk; M Heller
Journal:  Rofo       Date:  1993-11

9.  Assessment of human liver metabolism by phosphorus-31 magnetic resonance spectroscopy.

Authors:  R D Oberhaensli; G J Galloway; D J Taylor; P J Bore; G K Radda
Journal:  Br J Radiol       Date:  1986-07       Impact factor: 3.039

10.  A study of T1-weighted 31phosphorus MR-spectroscopy from patients with focal and diffuse liver disease.

Authors:  G Brinkmann; U H Melchert
Journal:  Magn Reson Imaging       Date:  1992       Impact factor: 2.546

View more
  1 in total

1.  Phosphodiester content measured in human liver by in vivo 31 P MR spectroscopy at 7 tesla.

Authors:  Lucian A B Purvis; William T Clarke; Ladislav Valkovič; Christina Levick; Michael Pavlides; Eleanor Barnes; Jeremy F Cobbold; Matthew D Robson; Christopher T Rodgers
Journal:  Magn Reson Med       Date:  2017-02-28       Impact factor: 4.668

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.